|
| 37418588 | SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent manner. | Mol Oncol | 2024 |
| 36980557 | Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach. | Cancers (Basel) | 2023 |
| 37120552 | Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. | Clin Epigenetics | 2023 |
| 37386095 | Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time. | Sci Rep | 2023 |
| 37209931 | Generation and characterization of a monoclonal antibody that binds to Galectin-1. | Protein Expr Purif | 2023 |
| 34294873 | Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer. | Prostate Cancer Prostatic Dis | 2022 |
| 35652618 | The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. | Prostate | 2022 |
| 35379845 | MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. | Nat Commun | 2022 |
| 35537621 | Quantifying absolute benefit for adjuvant treatment options in renal cell carcinoma: A living interactive systematic review and network meta-analysis. | Crit Rev Oncol Hematol | 2022 |
| 35718417 | Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity. | Heart Fail Clin | 2022 |
| 35628416 | MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets. | Int J Mol Sci | 2022 |
| 35094878 | Identification of a CD4<sup>+</sup> T cell line with Treg-like activity. | Hum Immunol | 2022 |
| 33069555 | Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma. | Urol Oncol | 2021 |
| 33829609 | Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR). | Oncologist | 2021 |
| 33547292 | Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. | Nat Commun | 2021 |
| 33824031 | A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma. | Eur Urol | 2021 |
| 33593912 | ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer. | Proc Natl Acad Sci U S A | 2021 |
| 34940094 | Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors. | Curr Oncol | 2021 |
| 34074655 | Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer. | Clin Cancer Res | 2021 |
| 33461589 | Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. | Clin Epigenetics | 2021 |
| 31575656 | Molecular Inhibitor of QSOX1 Suppresses Tumor Growth <i>In Vivo</i>. | Mol Cancer Ther | 2020 |
| 31959902 | Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. | Sci Rep | 2020 |
| 31829518 | Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma. | Cancer Med | 2020 |
| 33329980 | Evolving Natural History of Metastatic Prostate Cancer. | Cureus | 2020 |
| 33121461 | 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. | BMC Urol | 2020 |
| 32586940 | Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer. | Clin Cancer Res | 2020 |
| 32464345 | Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta. | Stem Cell Res | 2020 |
| 30406665 | Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation. | J Proteome Res | 2019 |
| 31180304 | Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis: case series and review of the literature. | Can J Urol | 2019 |
| 31361072 | In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma. | Cancer Med | 2019 |
| 30820020 | Germ Cell Tumors with Malignant Somatic Transformation: A Mayo Clinic Experience. | Oncol Res Treat | 2019 |
| 30391138 | Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study. | Clin Genitourin Cancer | 2019 |
| 29172746 | Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model. | Clin Exp Hypertens | 2018 |
| 30021908 | Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma. | Clin Cancer Res | 2018 |
| 30040854 | Behavior of blood plasma glycan features in bladder cancer. | PLoS One | 2018 |
| 29925010 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. | Cell Rep | 2018 |
| 30372397 | Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma. | J Clin Oncol | 2018 |
| 30345423 | Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis. | Eur Urol Oncol | 2018 |
| 29617669 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. | Cell Rep | 2018 |
| 29706106 | The Impact of Pazopanib on the Cardiovascular System. | J Cardiovasc Pharmacol Ther | 2018 |
| 29129073 | Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer. | J Proteome Res | 2018 |
| 29301960 | Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. | Science | 2018 |
| 27771244 | A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer. | Clin Genitourin Cancer | 2017 |
| 30761385 | Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma. | JCO Precis Oncol | 2017 |
| 28473535 | Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance. | Clin Cancer Res | 2017 |
| 28327121 | BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor. | BMC Urol | 2017 |
| 29497565 | Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development. | Cardiooncology | 2017 |
| 29256392 | Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia. | Elife | 2017 |
| 28976794 | Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma. | J Clin Oncol | 2017 |
| 28545997 | Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. | Clin Genitourin Cancer | 2017 |